What does Faeth Therapeutics, Inc. do?
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an…
What is Faeth Therapeutics, Inc.'s P/E and P/B ratio?
Faeth Therapeutics, Inc. has a P/E ratio of -0.3 and a P/B ratio of 3.00.
What is Faeth Therapeutics, Inc.'s debt-to-equity ratio?
Faeth Therapeutics, Inc. has a debt-to-equity ratio of 0.00.
How much does Faeth Therapeutics, Inc. owe compared with what it owns?
Faeth Therapeutics, Inc. owes $0.09 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Faeth Therapeutics, Inc.'s Positivity rank?
Faeth Therapeutics, Inc. is ranked #3,704 of 6,774 companies globally and #1,665 of 4,000 in United States on PositoAI, with a Positivity Score of 20,308.
Does Faeth Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Faeth Therapeutics, Inc..
Where can I read the latest news about Faeth Therapeutics, Inc.?
Recent headlines about Faeth Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Faeth Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Faeth Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.